FDA Approves Idaho Technology's Respiratory Viral Dx Panel with Added Targets

The FDA in February approved an earlier version of the FilmArray Respiratory Panel, but Idaho Tech chose not to commercialize that product, instead waiting for FDA approval of an updated version including two additional viral targets, the parainfluenza 1 and 2 viruses.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.